RECURRENT OVARIAN CANCER

Clinical trials for RECURRENT OVARIAN CANCER explained in plain language.

Never miss a new study

Get alerted when new RECURRENT OVARIAN CANCER trials appear

Sign up with your email to follow new studies for RECURRENT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 2 Not yet finished but already full! 1 Completed 3

Experimental drug combo targets tough cancers in first human trial

Disease control Ongoing

This early-stage study is testing whether adding an experimental drug called RP-6306 to standard chemotherapy (carboplatin and paclitaxel) is safe for patients with recurrent ovarian or uterine cancer that has a specific genetic change (TP53 mutation). The main goal is to find th…

Matched conditions: RECURRENT OVARIAN CANCER

Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

RECURRENT OVARIAN CANCER

Get alerted when new RECURRENT OVARIAN CANCER trials appear

Experimental drug combo targets tough cancers in first human trial